Portfolio (Quarterly)
Guide ↗
JOHNSON & JOHNSON
· CIK 0000200406| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PTGX | Protagonist Therapeutics Inc. | Healthcare | 2,449,183.0 | $258.1M | 39.57% | — | — | $105.40 | +34.6% |
| 2 | NBTX | Nanobiotix S.A. | Healthcare | 5,623,816.0 | $173.6M | 26.61% | — | — | $30.87 | +7.9% |
| 3 | MGTX | MeiraGTx Holdings plc | Healthcare | 6,641,064.0 | $57.5M | 8.82% | — | — | $8.66 | +26.0% |
| 4 | RAPP | Rapport Therapeutics, Inc. | Healthcare | 1,784,517.0 | $55.8M | 8.56% | — | — | $31.29 | +8.4% |
| 5 | CVRX | CVRx, Inc. | Healthcare | 4,024,861.0 | $38.1M | 5.84% | — | — | $9.46 | -71.5% |
| 6 | CTNM | Contineum Therapeutics Inc. | Healthcare | 1,979,173.0 | $25.8M | 3.96% | — | — | $13.06 | -3.8% |
| 7 | LEGN | Legend Biotech Corporation | Healthcare | 814,586.0 | $14.7M | 2.26% | — | — | $18.09 | +5.6% |
| 8 | XNCR | Xencor, Inc. | Healthcare | 748,062.0 | $9.0M | 1.38% | — | — | $12.06 | +97.3% |
| 9 | PRCT | Procept BioRobotics Corporation | Healthcare | 357,939.0 | $9.0M | 1.37% | — | — | $25.01 | -31.2% |
| 10 | FATE | Fate Therapeutics, Inc. | Healthcare | 3,379,064.0 | $4.1M | 0.62% | — | — | $1.20 | +95.8% |
| 11 | NMRA | Neumora Therapeutics, Inc. | Healthcare | 1,849,445.0 | $3.6M | 0.55% | — | — | $1.95 | -65.3% |
| 12 | RLYB | Rallybio Corporation | Healthcare | 152,901.0 | $1.4M | 0.21% | NEW | — | $8.97 | +85.3% |
| 13 | VOR | Vor Biopharma, Inc. | Healthcare | 53,732.0 | $959K | 0.15% | — | — | $17.84 | +3.8% |
| 14 | LAB | Standard BioTools, Inc. | Healthcare | 311,967.0 | $287K | 0.04% | — | — | $0.92 | -19.5% |
| 15 | NNOX | Nano-X Imaging Ltd. | Healthcare | 83,554.0 | $190K | 0.03% | -75K | -47.4% | $2.27 | -71.8% |
| 16 | — | Adicet Bio, Inc. | — | 22,779.0 | $155K | 0.02% | — | — | $6.81 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%